Valuation : Illumina, Inc.

Market Cap 32.55B 28.05B 26.3B 24.01B 45.23B 3,111B 45.37B 312B 122B 1,571B 122B 120B 5,208B P/E 2026 *
43.6x
P/E 2027 * 36.9x
Enterprise Value 32.8B 28.26B 26.5B 24.19B 45.57B 3,135B 45.72B 314B 123B 1,582B 123B 120B 5,247B EV / Sales 2026 *
7.09x
EV / Sales 2027 * 6.48x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day-5.31%
1 week-1.74%
Current month+5.11%
1 month+11.72%
3 months+35.85%
6 months+60.34%
Current year+64.37%
1 week 212.37
Extreme 212.37
231.81
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
471.1
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
27/08/26
Corvex Management LP
SellCompany -138,379 0.0915%
25/08/26 Other

Director

0 0%
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
Change 5-day change 1-year change 3-year change Capi.($)
-5.31%-1.74%+117.39%+36.28% 32.55B
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.36%-7.01%-55.71%-12.92% 67.88B
+0.29%+0.47%+11.06%+18.65% 52B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
+1.94%+3.81%-12.73%+48.46% 34.67B
Average -0.60%-0.93%+11.68%+17.28% 83.58B
Weighted average by Cap. -0.36%-1.31%+7.34%+10.92%

Financials

2026 *2027 *
Net sales 4.62B 3.99B 3.74B 3.41B 6.43B 442B 6.45B 44.33B 17.3B 223B 17.36B 16.99B 740B 4.91B 4.23B 3.97B 3.62B 6.82B 469B 6.84B 47.07B 18.37B 237B 18.44B 18.04B 786B
Net income 760M 655M 614M 561M 1.06B 72.67B 1.06B 7.29B 2.84B 36.68B 2.85B 2.79B 122B 891M 768M 720M 657M 1.24B 85.18B 1.24B 8.54B 3.33B 43B 3.35B 3.27B 143B
Net Debt 246M 212M 199M 181M 342M 23.51B 343M 2.36B 920M 11.87B 924M 904M 39.36B -729M -628M -589M -538M -1.01B -69.67B -1.02B -6.99B -2.73B -35.17B -2.74B -2.68B -117B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
28/08/26 $215.59 -5.31% 1,791,736
27/08/26 $227.69 +1.27% 1,937,242
26/08/26 $224.84 -0.07% 1,714,494
25/08/26 $224.99 +0.79% 1,918,113
24/08/26 $223.22 +1.74% 2,250,988
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
215.59USD
Average target price
198.89USD
Spread / Average Target
-7.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock